Clinical Trial Update: The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the antioxidant effects of N-acetylcysteine in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Siriraj Hospital | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED